Study finds elevated interleukin-12 levels correlate with increased fatigue in patients with immune thrombocytopenia, suggesting a new biomarker for treatment monitoring.
Key Points
Patients with immune thrombocytopenia reported significantly lower quality of life scores, indicating the impact of fatigue.
IL-12 levels were significantly higher in ITP patients compared to healthy controls, suggesting a link to fatigue.
Observational analysis revealed that increased IL-12 levels were independently associated with fatigue and lower quality of life scores.
Findings highlight the role of interleukin-12 as a potential immunologic marker for fatigue in immune thrombocytopenia patients.